Search results
Found 259 matches for
Body’s immune response may offer alternative approach to neuropathic pain therapies
Clinical Neurology Research
28 June 2023
In the midst of a global opioid epidemic, a team of scientists is exploring natural killer (NK) cells as an alternative treatment for neuropathic pain.
New programme to move potential MND drugs into clinical trials faster
Clinical Neurology Research
21 June 2023
A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease (MND, also known as ALS), is announced today on Global MND Awareness Day.
Researchers discover how cells handle the Parkinson’s disease-causing protein alpha-synuclein
Clinical Neurology Research
15 June 2023
Beacon Therapeutics launched to develop new generation of gene therapies for retinal diseases
Ophthalmology Research
12 June 2023
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease
Clinical Neurology Research
26 May 2023
The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
Colin Espie becomes a Fellow of the Academy of Medical Sciences
Ophthalmology Research
18 May 2023
Professor Espie is one of eight Oxford researchers to become Fellows of the Academy of Medical Sciences.
Oxford Epilepsy Research Group Papers Highlighted
Clinical Neurology Publication Research
2 May 2023
Two papers by early career researchers in our Oxford Epilepsy Research Group have been highlighted recently.
Study shows need for greater screening for frailty in emergency hospital admissions
Research Stroke & Dementia
26 April 2023
A new study has shown the need for more widespread screening for frailty in unplanned admissions to hospitals to better inform the care received by patients.
Surgery for sciatica reduces leg pain and disability, but benefits are short-lived
Clinical Neurology Research
20 April 2023
And the certainty of evidence supporting its use is low, say researchers
European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers
Clinical Neurology Research
14 March 2023
The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe
Two NDCN students join BNA Scholars Programme
Research
9 March 2023
The British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.
Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's
MRC BNDU Research
7 March 2023
The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.
Ophthalmology Conference in Kyiv
Ophthalmology Research
6 March 2023
On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.
Bioelectronic implant offers an intelligent therapy to treat incontinence
Clinical Neurology MRC BNDU Research
31 January 2023
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.
Direct evidence of reduced NMDA receptors in people with form of encephalitis
Clinical Neurology Research
3 January 2023
NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.
Director of MRC Brain Network Dynamics Unit appointed
MRC BNDU Research
15 December 2022
From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.
The risk of seizures and epilepsy is higher after COVID than after the flu
Clinical Neurology Coronavirus Research
21 November 2022
Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections
Anaesthetics Coronavirus Research
14 November 2022
New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.
New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models
Clinical Neurology Research
10 November 2022
Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
Visit from the Sir Jules Thorn Charitable Trust
Ophthalmology Research
19 October 2022
Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.